Elevated proinflammatory cytokine production by a skewed T cell compartment requires monocytes and promotes inflammation in type 2 diabetes

Journal of Immunology

Volumn 186, Issue 2, 2011, Pages 1162-1172

  Jagannathan Bogdan, Madhumita ^a   McDonnell, Marie E ^b   Shin, Hyunjin ^a   Rehman, Qasim ^b   Hasturk, Hatice ^c   Apovian, Caroline M ^b   Nikolajczyk, Barbara S ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON MEDICAL CENTER   (United States)

^c BOSTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 4;

ARTICLE; CD4+ T LYMPHOCYTE; CELL COMPARTMENTALIZATION; CELL CULTURE; CELLULAR IMMUNITY; CHRONIC INFLAMMATION; CYTOKINE PRODUCTION; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; INSULIN RESISTANCE; LYMPHOCYTE ACTIVATION; MAJOR CLINICAL STUDY; MALE; MONOCYTE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE; TH1 CELL; TH17 CELL;

ADULT; AGED; CELL DIFFERENTIATION; CELLS, CULTURED; COCULTURE TECHNIQUES; CROSS-SECTIONAL STUDIES; CYTOKINES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; INTERFERON-GAMMA; INTERLEUKIN-17; MALE; MIDDLE AGED; MONOCYTES; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 79251589063     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1002615     Document Type: Article

References (67)

1. Sutton, C., C. Brereton, B. Keogh, K. H. Mills, and E. C. Lavelle. 2006. A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis. J. Exp. Med. 203: 1685-1691.
2. Furuzawa-Carballeda, J., M. I. Vargas-Rojas, and A. R. Cabral. 2007. Autoimmune inflammation from the Th17 perspective. Autoimmun. Rev. 6: 169-175.
3. Hsu, H. C., P. Yang, J. Wang, Q. Wu, R. Myers, J. Chen, J. Yi, T. Guentert, A. Tousson, A. L. Stanus, et al. 2008. Interleukin 17-producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice. Nat. Immunol. 9: 166-175.
4. Galicia, G., A. Kasran, C. Uyttenhove, K. De Swert, J. Van Snick, and J. L. Ceuppens. 2009. ICOS deficiency results in exacerbated IL-17 mediated experimental autoimmune encephalomyelitis. J. Clin. Immunol. 29: 426-433.
5. Komiyama, Y., S. Nakae, T. Matsuki, A. Nambu, H. Ishigame, S. Kakuta, K. Sudo, and Y. Iwakura. 2006. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J. Immunol. 177: 566-573.
6. Pène, J., S. Chevalier, L. Preisser, E. Vénéreau, M. H. Guilleux, S. Ghannam, J. P. Molès, Y. Danger, E. Ravon, S. Lesaux, et al. 2008. Chronically inflamed human tissues are infiltrated by highly differentiated Th17 lymphocytes. J. Immunol. 180: 7423-7430.
7. Moseley, T. A., D. R. Haudenschild, L. Rose, and A. H. Reddi. 2003. Interleukin-17 family and IL-17 receptors. Cytokine Growth Factor Rev. 14: 155-174.
8. Schwandner, R., K. Yamaguchi, and Z. Cao. 2000. Requirement of tumor necrosis factor receptor-associated factor (TRAF)6 in interleukin 17 signal transduction. J. Exp. Med. 191: 1233-1240.
9. Onishi, R. M., and S. L. Gaffen. 2010. Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease. Immunology 129: 311-321.
10. Kolls, J. K., and A. Lindén. 2004. Interleukin-17 family members and inflammation. Immunity 21: 467-476.
11. Mosser, D. M., and J. P. Edwards. 2008. Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 8: 958-969.
12. Tilg, H., and A. R. Moschen. 2008. Inflammatory mechanisms in the regulation of insulin resistance. Mol. Med. 14: 222-231.
13. Spranger, J., A. Kroke, M. Möhlig, K. Hoffmann, M. M. Bergmann, M. Ristow, H. Boeing, and A. F. Pfeiffer. 2003. Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes 52: 812-817.
14. Grimble, R. F. 2002. Inflammatory status and insulin resistance. Curr. Opin. Clin. Nutr. Metab. Care 5: 551-559.
15. Pickup, J. C. 2004. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care 27: 813-823.
16. Pickup, J. C., and M. A. Crook. 1998. Is type II diabetes mellitus a disease of the innate immune system? Diabetologia 41: 1241-1248.
17. Giulietti, A., E. van Etten, L. Overbergh, K. Stoffels, R. Bouillon, and C. Mathieu. 2007. Monocytes from type 2 diabetic patients have a proinflammatory profile. 1,25-Dihydroxyvitamin D(3) works as anti-inflammatory. Diabetes Res. Clin. Pract. 77: 47-57.
18. Hatanaka, E., P. T. Monteagudo, M. S. Marrocos, and A. Campa. 2006. Neutrophils and monocytes as potentially important sources of proinflammatory cytokines in diabetes. Clin. Exp. Immunol. 146: 443-447.
19. Jagannathan, M., M. McDonnell, Y. Liang, H. Hasturk, J. Hetzel, D. Rubin, A. Kantarci, T. E. Van Dyke, L. M. Ganley-Leal, and B. S. Nikolajczyk. 2010. Toll-like receptors regulate B cell cytokine production in patients with diabetes. Diabetologia 53: 1461-1471.
20. Yuan, M., N. Konstantopoulos, J. Lee, L. Hansen, Z. W. Li, M. Karin, and S. E. Shoelson. 2001. Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta. Science 293: 1673-1677.
21. Arkan, M. C., A. L. Hevener, F. R. Greten, S. Maeda, Z. W. Li, J. M. Long, A. Wynshaw-Boris, G. Poli, J. Olefsky, and M. Karin. 2005. IKK-beta links inflammation to obesity-induced insulin resistance. Nat. Med. 11: 191-198.
22. de Roos, B., V. Rungapamestry, K. Ross, G. Rucklidge, M. Reid, G. Duncan, G. Horgan, S. Toomey, J. Browne, C. E. Loscher, et al. 2009. Attenuation of inflammation and cellular stress-related pathways maintains insulin sensitivity in obese type I interleukin-1 receptor knockout mice on a high-fat diet. Proteomics 9: 3244-3256.
23. Ehses, J. A., G. Lacraz, M. H. Giroix, F. Schmidlin, J. Coulaud, N. Kassis, J. C. Irminger, M. Kergoat, B. Portha, F. Homo-Delarche, and M. Y. Donath. 2009. IL-1 antagonism reduces hyperglycemia and tissue inflammation in the type 2 diabetic GK rat. Proc. Natl. Acad. Sci. USA 106: 13998-14003.
24. Reimers, J. I. 1998. Interleukin-1 beta induced transient diabetes mellitus in rats. A model of the initial events in the pathogenesis of insulin-dependent diabetes mellitus? Dan. Med. Bull. 45: 157-180.
25. Cai, D., M. Yuan, D. F. Frantz, P. A. Melendez, L. Hansen, J. Lee, and S. E. Shoelson. 2005. Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat. Med. 11: 183-190.
26. Feuerer, M., L. Herrero, D. Cipolletta, A. Naaz, J. Wong, A. Nayer, J. Lee, A. B. Goldfine, C. Benoist, S. Shoelson, and D. Mathis. 2009. Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat. Med. 15: 930-939.
27. Winer, S., Y. Chan, G. Paltser, D. Truong, H. Tsui, J. Bahrami, R. Dorfman, Y. Wang, J. Zielenski, F. Mastronardi, et al. 2009. Normalization of obesity-associated insulin resistance through immunotherapy. Nat. Med. 15: 921-929.
28. Winer, S., G. Paltser, Y. Chan, H. Tsui, E. Engleman, D. Winer, and H. M. Dosch. 2009. Obesity predisposes to Th17 bias. Eur. J. Immunol. 39: 2629-2635.
29. Herder, C., A. Zierer, W. Koenig, M. Roden, C. Meisinger, and B. Thorand. 2009. Transforming growth factor-beta1 and incident type 2 diabetes: results from the MONICA/KORA case-cohort study, 1984-2002. Diabetes Care 32: 1921-1923.
30. Andriankaja, O. M., S. P. Barros, K. Moss, F. S. Panagakos, W. DeVizio, J. Beck, and S. Offenbacher. 2009. Levels of serum interleukin (IL)-6 and gingival crevicular fluid of IL-1beta and prostaglandin E(2) among non-smoking subjects with gingivitis and type 2 diabetes. J. Periodontol. 80: 307-316.
31. Osborn, O., S. E. Brownell, M. Sanchez-Alavez, D. Salomon, H. Gram, and T. Bartfai. 2008. Treatment with an Interleukin 1 beta antibody improves glycemic control in diet-induced obesity. Cytokine 44: 141-148.
32. Yang, L., D. E. Anderson, C. Baecher-Allan, W. D. Hastings, E. Bettelli, M. Oukka, V. K. Kuchroo, and D. A. Hafler. 2008. IL-21 and TGF-beta are required for differentiation of human T(H)17 cells. Nature 454: 350-352.
33. Acosta-Rodriguez, E. V., G. Napolitani, A. Lanzavecchia, and F. Sallusto. 2007. Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat. Immunol. 8: 942-949.
34. Liang, M. D., Y. Zhang, D. McDevit, S. Marecki, and B. S. Nikolajczyk. 2006. The interleukin-1beta gene is transcribed from a poised promoter architecture in monocytes. J. Biol. Chem. 281: 9227-9237.
35. Acosta-Rodriguez, E. V., L. Rivino, J. Geginat, D. Jarrossay, M. Gattorno, A. Lanzavecchia, F. Sallusto, and G. Napolitani. 2007. Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat. Immunol. 8: 639-646.
36. Maggi, L., V. Santarlasci, M. Capone, A. Peired, F. Frosali, S. Q. Crome, V. Querci, M. Fambrini, F. Liotta, M. K. Levings, et al. 2010. CD161 is a marker of all human IL-17-producing T-cell subsets and is induced by RORC. Eur. J. Immunol. 40: 2174-2181.
37. Diveu, C., M. J. McGeachy, K. Boniface, J. S. Stumhofer, M. Sathe, B. Joyce-Shaikh, Y. Chen, C. M. Tato, T. K. McClanahan, R. de Waal Malefyt, et al. 2009. IL-27 blocks RORc expression to inhibit lineage commitment of Th17 cells. J. Immunol. 182: 5748-5756.
38. Manel, N., D. Unutmaz, and D. R. Littman. 2008. The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat. Nat. Immunol. 9: 641-649.
39. Ivanov, I. I., B. S. McKenzie, L. Zhou, C. E. Tadokoro, A. Lepelley, J. J. Lafaille, D. J. Cua, and D. R. Littman. 2006. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126: 1121-1133.
40. Rachitskaya, A. V., A. M. Hansen, R. Horai, Z. Li, R. Villasmil, D. Luger, R. B. Nussenblatt, and R. R. Caspi. 2008. Cutting edge: NKT cells constitutively express IL-23 receptor and RORgammat and rapidly produce IL-17 upon receptor ligation in an IL-6-independent fashion. J. Immunol. 180: 5167-5171.
41. Bradshaw, E. M., K. Raddassi, W. Elyaman, T. Orban, P. A. Gottlieb, S. C. Kent, and D. A. Hafler. 2009. Monocytes from patients with type 1 diabetes spontaneously secrete proinflammatory cytokines inducing Th17 cells. J. Immunol. 183: 4432-4439.
42. Evans, H. G., N. J. Gullick, S. Kelly, C. Pitzalis, G. M. Lord, B.W. Kirkham, and L. S. Taams. 2009. In vivo activated monocytes from the site of inflammation in humans specifically promote Th17 responses. Proc. Natl. Acad. Sci. USA 106: 6232-6237.
43. Iwamoto, S., S. Iwai, K. Tsujiyama, C. Kurahashi, K. Takeshita, M. Naoe, A. Masunaga, Y. Ogawa, K. Oguchi, and A. Miyazaki. 2007. TNF-alpha drives human CD14+ monocytes to differentiate into CD70+ dendritic cells evoking Th1 and Th17 responses. J. Immunol. 179: 1449-1457.
44. Zaba, L. C., J. Fuentes-Duculan, N. J. Eungdamrong, M. V. Abello, I. Novitskaya, K. C. Pierson, J. Gonzalez, J. G. Krueger, and M. A. Lowes. 2009. Psoriasis is characterized by accumulation of immunostimulatory and Th1/Th17 cell-polarizing myeloid dendritic cells. J. Invest. Dermatol. 129: 79-88.
45. Awasthi, A., and V. K. Kuchroo. 2009. Th17 cells: from precursors to players in inflammation and infection. Int. Immunol. 21: 489-498.
46. Horwitz, D. A., S. G. Zheng, J. Wang, and J. D. Gray. 2008. Critical role of IL-2 and TGF-beta in generation, function and stabilization of Foxp3+CD4+ Treg. Eur. J. Immunol. 38: 912-915.
47. Maloy, K. J., and F. Powrie. 2005. Fueling regulation: IL-2 keeps CD4+ Treg cells fit. Nat. Immunol. 6: 1071-1072.
48. Murawski, M. R., S. A. Litherland, M. J. Clare-Salzler, and A. Davoodi-Semiromi. 2006. Upregulation of Foxp3 expression in mouse and human Treg is IL-2/STAT5 dependent: implications for the NOD STAT5B mutation in diabetes pathogenesis. Ann. N. Y. Acad. Sci. 1079: 198-204.
49. Schneider, A., M. Rieck, S. Sanda, C. Pihoker, C. Greenbaum, and J. H. Buckner. 2008. The effector T cells of diabetic subjects are resistant to regulation via CD4+ FOXP3+ regulatory T cells. J. Immunol. 181: 7350-7355.
50. Brusko, T. M., C. H. Wasserfall, M. J. Clare-Salzler, D. A. Schatz, and M. A. Atkinson. 2005. Functional defects and the influence of age on the frequency of CD4+ CD25+ T-cells in type 1 diabetes. Diabetes 54: 1407-1414.
51. Lindley, S., C. M. Dayan, A. Bishop, B. O. Roep, M. Peakman, and T. I. Tree. 2005. Defective suppressor function in CD4(+)CD25(+) T-cells from patients with type 1 diabetes. Diabetes 54: 92-99.
52. Norberg, M., J. W. Eriksson, B. Lindahl, C. Andersson, O. Rolandsson, H. Stenlund, and L. Weinehall. 2006. A combination of HbA1c, fasting glucose and BMI is effective in screening for individuals at risk of future type 2 diabetes: OGTT is not needed. J. Intern. Med. 260: 263-271.
53. Haimoto, H., T. Sasakabe, H. Umegaki, and K. Wakai. 2009. Acute metabolic responses to a high-carbohydrate meal in outpatients with type 2 diabetes treated with a low-carbohydrate diet: a crossover meal tolerance study. Nutr. Metab. (Lond) 6: 52.
54. McGillicuddy, F. C., E. H. Chiquoine, C. C. Hinkle, R. J. Kim, R. Shah, H. M. Roche, E. M. Smyth, and M. P. Reilly. 2009. Interferon gamma attenuates insulin signaling, lipid storage, and differentiation in human adipocytes via activation of the JAK/STAT pathway. J. Biol. Chem. 284: 31936-31944.
55. Fain, J. N. 2006. Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells. Vitam. Horm. 74: 443-477.
56. Shoelson, S. E., L. Herrero, and A. Naaz. 2007. Obesity, inflammation, and insulin resistance. Gastroenterology 132: 2169-2180.
57. Wegner, M., H. Winiarska, T. Bobkiewicz-Kozłowska, and M. Dworacka. 2008. IL-12 serum levels in patients with type 2 diabetes treated with sulphonylureas. Cytokine 42: 312-316.
58. Tsiavou, A., D. Degiannis, E. Hatziagelaki, K. Koniavitou, and S. A. Raptis. 2004. Intracellular IFN-gamma production and IL-12 serum levels in latent autoimmune diabetes of adults (LADA) and in type 2 diabetes. J. Interferon Cytokine Res. 24: 381-387.
59. Manetti, R., P. Parronchi, M. G. Giudizi, M. P. Piccinni, E. Maggi, G. Trinchieri, and S. Romagnani. 1993. Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J. Exp. Med. 177: 1199-1204.
60. Wu, C. Y., C. Demeure, M. Kiniwa, M. Gately, and G. Delespesse. 1993. IL-12 induces the production of IFN-gamma by neonatal human CD4 T cells. J. Immunol. 151: 1938-1949.
61. Yssel, H., S. Fasler, J. E. de Vries, and R. de Waal Malefyt. 1994. IL-12 transiently induces IFN-gamma transcription and protein synthesis in human CD4+ allergen-specific Th2 T cell clones. Int. Immunol. 6: 1091-1096.
62. Puddu, P., L. Fantuzzi, P. Borghi, B. Varano, G. Rainaldi, E. Guillemard, W. Malorni, P. Nicaise, S. F. Wolf, F. Belardelli, and S. Gessani. 1997. IL-12 induces IFN-gamma expression and secretion in mouse peritoneal macrophages. J. Immunol. 159: 3490-3497.
63. Shin, J. H., D. W. Shin, and M. Noh. 2009. Interleukin-17A inhibits adipocyte differentiation in human mesenchymal stem cells and regulates proinflammatory responses in adipocytes. Biochem. Pharmacol. 77: 1835-1844.
64. Lim, H. W., J. Lee, P. Hillsamer, and C. H. Kim. 2008. Human Th17 cells share major trafficking receptors with both polarized effector T cells and FOXP3+ regulatory T cells. J. Immunol. 180: 122-129.
65. Ayyoub, M., F. Deknuydt, I. Raimbaud, C. Dousset, L. Leveque, G. Bioley, and D. Valmori. 2009. Human memory FOXP3+ Tregs secrete IL-17 ex vivo and constitutively express the T(H)17 lineage-specific transcription factor RORgamma t. Proc. Natl. Acad. Sci. USA 106: 8635-8640.
66. Koenen, H. J., R. L. Smeets, P. M. Vink, E. van Rijssen, A. M. Boots, and I. Joosten. 2008. Human CD25 high Foxp3pos regulatory T cells differentiate into IL-17-producing cells. Blood 112: 2340-2352.
67. Xu, L., A. Kitani, I. Fuss, and W. Strober. 2007. Cutting edge: regulatory T cells induce CD4+CD25-Foxp3- T cells or are self-induced to become Th17 cells in the absence of exogenous TGF-beta. J. Immunol. 178: 6725-6729.